News + Filings Transactions
|
O'Farrell Elizabeth G.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/24/2023 | GERON CORP | GERN | Purchase | Common Stock | 6.6k | $2.28 | $15k | By Spouse | 08/24/2023 |
| 08/24/2023 | GERON CORP | GERN | Purchase | Common Stock | 6.6k | $2.28 | $15.1k | | 08/24/2023 |
| 05/31/2023 | GERON CORP | GERN | Grant | Stock Option (right to buy) | 125k | $3.27 | $408.8k | | 05/31/2023 |
| 05/25/2023 | LENSAR, Inc. | | Grant | Stock Option (Right to Buy) | 33.2k | $3.23 | $107.2k | | 05/25/2023 |
| 05/25/2023 | LENSAR, Inc. | | Grant | Common Stock | 9.3k | $0.00 | $0 | | 05/25/2023 |
| 06/24/2022 | Inhibikase Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 40k | $0.81 | $32.4k | | 06/24/2022 |
| 05/25/2022 | LENSAR, Inc. | | Grant | Common Stock | 4.3k | $0.00 | $0 | | 05/25/2022 |
| 05/25/2022 | LENSAR, Inc. | | Grant | Stock Option (Right to Buy) | 15.6k | $7.00 | $109.3k | | 05/25/2022 |
| 05/10/2022 | GERON CORP | GERN | Grant | Stock Option (right to buy) | 125k | $1.48 | $185k | | 05/10/2022 |
| 06/25/2021 | Inhibikase Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 22.7k | $2.92 | $66.2k | | 06/25/2021 |
| 05/18/2021 | LENSAR, Inc. | | Grant | Stock Option (Right to Buy) | 20.8k | $7.49 | $156.1k | | 05/18/2021 |
| 05/11/2021 | GERON CORP | GERN | Grant | Stock Option (right to buy) | 83k | $1.39 | $115.4k | | 05/11/2021 |
| 03/12/2021 | LENSAR, Inc. | | Grant | Stock Option (Right to Buy) | 13.4k | $8.62 | $115.9k | | 03/12/2021 |
| 02/01/2021 | LENSAR, Inc. | | Grant | Stock Option (Right to Buy) | 28.2k | $7.08 | $200k | | 02/01/2021 |
| 12/22/2020 | Inhibikase Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 6.8k | $10.00 | $68.2k | | 12/22/2020 |
| 11/23/2020 | PDL BIOPHARMA, INC. | PDLI | Sale | Common stock | 25.8k | $2.44 | $63k | | 11/23/2020 |
| 11/18/2020 | PDL BIOPHARMA, INC. | PDLI | Sale | Common stock | 63.3k | $2.38 | $150.7k | | 11/18/2020 |
| 08/21/2020 | GERON CORP | GERN | Purchase | Common Stock | 17.4k | $1.73 | $30.2k | By Spouse | 08/21/2020 |
| 08/19/2020 | PDL BIOPHARMA, INC. | PDLI | Grant | Stock Option (right to buy) | 118.7k | $3.63 | $430.8k | | 08/19/2020 |
| 08/19/2020 | PDL BIOPHARMA, INC. | PDLI | Grant | Common stock | 25.8k | $0.00 | $0 | | 08/19/2020 |
| 06/05/2020 | GERON CORP | GERN | Grant | Stock Option (right to buy) | 83k | $1.54 | $127.8k | | 06/05/2020 |
| 01/10/2020 | GERON CORP | GERN | Purchase | Common Stock | 800 | $1.35 | $1.1k | | 01/10/2020 |
| 01/10/2020 | GERON CORP | GERN | Purchase | Common Stock | 2.2k | $1.34 | $2.9k | By Spouse | 01/10/2020 |
| 06/20/2019 | PDL BIOPHARMA, INC. | PDLI | Grant | Stock Option (right to buy) | 126k | $3.00 | $378.2k | | 06/20/2019 |
| 06/06/2019 | GERON CORP | GERN | Grant | Stock Option (right to buy) | 70k | $1.38 | $96.6k | | 06/06/2019 |
| 03/26/2019 | GERON CORP | GERN | Grant | Stock Option (right to buy) | 120k | $1.68 | $201.6k | | 03/26/2019 |
| 06/22/2018 | PDL BIOPHARMA, INC. | PDLI | Grant | Common stock | 63.3k | $2.37 | $150k | | 06/22/2018 |
|